Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program:Quantitative Analysis
Background: The Dutch Institute for Clinical Auditing (DICA) Medicines Program was set up in September 2018 to evaluate expensive medicine use in daily practice in terms of real-world effectiveness using only existing data sources. Objective: The aim of this study is to describe the potential of the addition of declaration data to quality registries to provide participating centers with benchmark information about the use of medicines and outcomes among patients. Methods: A total of 3 national population-based registries were linked to clinical and financial data from the hospital pharmacy, th... Mehr ...
Verfasser: |
Ismail, Rawa Kamaran
van Breeschoten, Jesper
van der Flier, Silvia
van Loosen, Caspar
Pasmooij, Anna Maria Gerdina
van Dartel, Maaike
van den Eertwegh, Alfons
de Boer, Anthonius
Wouters, Michel
Hilarius, Doranne |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2022 |
Reihe/Periodikum: |
Ismail , R K , van Breeschoten , J , van der Flier , S , van Loosen , C , Pasmooij , A M G , van Dartel , M , van den Eertwegh , A , de Boer , A , Wouters , M & Hilarius , D 2022 , ' Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program : Quantitative Analysis ' , Journal of Medical Internet Research , vol. 24 , no. 6 , e33446 . https://doi.org/10.2196/33446 |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-29047416 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://research.vumc.nl/en/publications/7ffd48fb-74bb-4aa6-803c-322caee65b8d |